Cannell Capital’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
GGHC
Cannell Capital's VCYT Position: Q2 2020 in Review
Cannell Capital sold out of Veracyte (VCYT) in Q2 2020, closing a stake of 296,340 shares — an estimated $7.2M sold.
Cannell Capital first reported a position in VCYT in Q3 2016 and held it in 15 quarters. The position peaked at $31.7M in Q1 2019. 166 funds tracked by Wall St. Rank hold VCYT as of Q2 2020.
- Cannell Capital reported no remaining Veracyte position as of Q2 2020 after selling out during the quarter.
- Cannell Capital sold 296,340 Veracyte shares in Q2 2020, an estimated $7.2M.
- Cannell Capital first reported a position in Veracyte in Q3 2016 and held it in 15 quarters.
- Cannell Capital's Veracyte position peaked at $31.7M in Q1 2019.
- 166 funds tracked by Wall St. Rank held Veracyte as of Q2 2020.
Based on Cannell Capital's 13F filing for Q2 2020, filed 14 Aug 2020.